CDMO

Celularity Inc. (NASDAQ: CELU) is a clinical and commercial stage biotechnology company developing and commercializing off-the-shelf placental-derived allogeneic cell therapies and advanced biomaterial products targeting age-related diseases and serious unmet medical needs. Its platform includes mesenchymal-like adherent stromal cells (MLASCs), Natural Killer (NK) cells, and engineered T cells including CAR-T cells. It operates a purpose-built 150,000 sq ft facility in Florham Park, NJ.

biobankingbiosourcingcell selectioncellular medicine manufacturingcryopreservationin-house cGMP manufacturingtranslational research

Cosette Pharmaceuticals is a U.S.-based, innovative branded specialty pharmaceutical company headquartered in Bridgewater, NJ. Building on more than a century of pharmaceutical heritage, it develops, manufactures, and commercializes high-profile brands across cardiovascular, neurology, pain management, women's health, critical care, rheumatology, and oncology, with more than 30 new products launched since 2022.

commercializationmanufacturingpackagingstrategic acquisitions

EUROAPI is a world leader in active pharmaceutical ingredients (APIs) with approximately 200 products in its portfolio, offering a large span of technologies while developing innovative molecules through its Contract Development and Manufacturing Organization (CDMO). The company aims to secure the core of the healthcare value chain, providing high-quality and sustainable API solutions to pharmaceutical and biotech clients across more than 80 countries, with around 3,100 employees and 5 production sites in Europe.

API manufacturingmicrobial fermentationmicronizationparticle engineeringsmall molecules synthesis